Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000254
Chunk: 3

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 3
---
30, 2024                                  |    2 |
|                                 | Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2024, and 2023 (Unaudited)           |    3 |
|                                 | Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended September 30, 2024, and 2023 (Unaudited)   |    4 |
|                                 | Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended September 30, 2024, and 2023 (Unaudited) |    5 |
|                                 | Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2024, and 2023 (Unaudited)           |    6 |
|                                 | Notes to the Condensed Consolidated Financial Statements (Unaudited)                                                          |    7 |
| Item 2.                         | Management’s Discussion and Analysis of Financial Condition and Results of Operations                                         |   20 |
| Item 3.                         | Quantitative and Qualitative Disclosures About Market Risk                                                                    |   32 |
| Item 4.                         | Controls and Procedures                                                                                                       |   32 |
| PART II – OTHER INFORMATION:    |                                                                                                                               |   33 |
| Item 1.                         | Legal Proceedings                                                                                                             |   33 |
| Item 1A.                        | Risk Factors                                                                                                                  |   35 |
| Item 2.                         | Unregistered Sales of Equity Securities and Use of Proceeds                                                                   |   35 |
| Item 3.                         | Defaults Upon Senior Securities                                                                                               |   35 |
| Item 4.                         | Mine Safety Disclosures                                                                                                       |   35 |
| Item 5.                         | Other Information                                                                                                             |   35 |
| Item 6.                         | Exhibits                                                                                                                      |   36 |
| Signatures                      |                                                                                                                               |   37 |

<div align='center'>i

PART I – FINANCIAL INFORMATION</div>

Item 1. Financial Statements.

The accompanying financial statements
have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with
the instructions for Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting
principles for complete financial statements.

In the opinion of management, the
financial statements contain all material adjustments, consisting only of normal recurring